http://orcid.org/0000-0002-6380-9662
About the Authors
- Lit Yeen Tan
-
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
- Samantha Michelle Walker
-
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
- Tina Lonergan
-
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
- Nicole Elizabeth Lima
-
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
- Alison Velyian Todd
-
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
- Elisa Mokany
-
* E-mail: elisam@speedx.com.au
Affiliation SpeeDx Pty Ltd, Eveleigh, NSW, Australia
Competing Interests
The authors EM, AT, LT, TL, SW and NL are employed by SpeeDx PTY LTD and have shares and/or options in the company. AT & EM are inventors on the PlexZyme™ patent families WO 2007/041774 and WO 2007/041774 and AT, EM, SW, TL and LT are inventors on the PlexPrime™ patent family WO 2013/123552. Biocartis NV sell a range of Idylla Tests and Assays which contain PlexZyme™ and PlexPrime™ technology under license from SpeeDx Pty Ltd. These interests do not alter our adherence toPLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: EM AT LT. Formal analysis: EM AT LT TL SW NL. Funding acquisition: AT EM. Investigation: EM LT TL SW NL. Methodology: EM AT LT TL SW NL. Project administration: EM AT LT. Software: LT SW EM. Supervision: EM AT LT. Validation: EM AT LT TL SW NL. Visualization: EM AT LT. Writing – original draft: EM AT LT. Writing – review & editing: EM AT LT.